Evidence map›Paper›PMID 24973690›Full record

ArticleBone2014

Runx2 is required for early stages of endochondral bone formation but delays final stages of bone repair in Axin2-deficient mice.

Meghan E McGee-Lawrence, Lomeli R Carpio, Elizabeth W Bradley, Amel Dudakovic, Jane B Lian, Andre J van Wijnen, Sanjeev Kakar, Wei Hsu, Jennifer J Westendorf

Abstract read
In one paragraph

Article in Bone, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 52 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. JBMR plus · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Cellular biology of fracture healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2019
    Review
  18. Article
  19. Article
  20. Histone Deacetylase 3 Deletion in Mesenchymal Progenitor Cells Hinders Long Bone Development.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Meghan E McGee-LawrenceMayo Clinic, Rochester, MN, USA.
Lomeli R CarpioMayo Clinic, Rochester, MN, USA.
Elizabeth W BradleyMayo Clinic, Rochester, MN, USA.
Amel DudakovicMayo Clinic, Rochester, MN, USA.
Jane B LianUniversity of Vermont, Burlington, VT, USA.
Andre J van WijnenMayo Clinic, Rochester, MN, USA.
Sanjeev KakarMayo Clinic, Rochester, MN, USA.
Wei HsuUniversity of Rochester Medical Center, Rochester, NY, USA.
Jennifer J WestendorfMayo Clinic, Rochester, MN, USA. Electronic address: westendorf.jennifer@mayo.edu.
Mayo Clinic in Arizona · USMayo Clinic · USMayo Clinic in Florida · USUniversity of Rochester Medical Center · USUniversity of Vermont · US

Funding

GENETIC REGULATORY NETWORK IN CRANIOFACIAL DEVELOPMENTR01DE015654 · NIDCR · UNIVERSITY OF ROCHESTER · PI Wei Hsu · 2006 to 2026
$8.2M
Musculoskeletal Research Training ProgramT32AR056950 · NIAMS · MAYO CLINIC ROCHESTER · PI Jennifer J Westendorf · 2009 to 2026
$7.0M
Synthesis of Osteocalcin in BoneR37DE012528 · NIDCR · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LIAN, JANE B. · 2008 to 2017
$5.0M
Runx2 and Axin2 Interactions During Bone FormationR01DE020194 · NIDCR · MAYO CLINIC ROCHESTER · PI WESTENDORF, JENNIFER J · 2010 to 2014
$2.1M
Runx2 and Axin2 Interactions During Bone FormationF32AR061873 · NIAMS · MAYO CLINIC ROCHESTER · PI BRADLEY, ELIZABETH W · 2011 to 2012
$109k
Relationship between Hdac3 suppression and Wnt signaling in osteoblastsF32AR060140 · NIAMS · MAYO CLINIC ROCHESTER · PI MCGEE-LAWRENCE, MEGHAN E. · 2010 to 2011
$99k
NIAMS NIH HHS F32 AR060140NIAMS NIH HHS F32 AR061873NIAMS NIH HHS F32 AR60140NIAMS NIH HHS T32 AR056950NIDCR NIH HHS R01 DE015654NIDCR NIH HHS R01 DE020194NIDCR NIH HHS R37 DE012528
6 · The paper itself

Abstract

Runx2 and Axin2 regulate skeletal development. We recently determined that Axin2 and Runx2 molecularly interact in differentiating osteoblasts to regulate intramembranous bone formation, but the relationship between these factors in endochondral bone formation was unresolved. To address this, we examined the effects of Axin2 deficiency on the cleidocranial dysplasia (CCD) phenotype of Runx2(+/-) mice, focusing on skeletal defects attributed to improper endochondral bone formation. Axin2 deficiency unexpectedly exacerbated calvarial components of the CCD phenotype in the Runx2(+/-) mice; the endocranial layer of the frontal suture, which develops by endochondral bone formation, failed to mineralize in Axin2(-/-):Runx2(+/-) mice, resulting in a cartilaginous, fibrotic and larger fontanel than observed in Runx2(+/-) mice. Transcripts associated with cartilage development (e.g., Acan, miR140) were expressed at higher levels, whereas blood vessel morphogenesis transcripts (e.g., Slit2) were suppressed in Axin2(-/-):Runx2(+/-) calvaria. Cartilage maturation was impaired, as primary chondrocytes from double mutant mice demonstrated delayed differentiation and produced less calcified matrix in vitro. The genetic dominance of Runx2 was also reflected during endochondral fracture repair, as both Runx2(+/-) and double mutant Axin2(-/-):Runx2(+/-) mice had enlarged fracture calluses at early stages of healing. However, by the end stages of fracture healing, double mutant animals diverged from the Runx2(+/-) mice, showing smaller calluses and increased torsional strength indicative of more rapid end stage bone formation as seen in the Axin2(-/-) mice. Taken together, our data demonstrate a dominant role for Runx2 in chondrocyte maturation, but implicate Axin2 as an important modulator of the terminal stages of endochondral bone formation.

Indexed as

OsteogenesisWound HealingAnimalsAxin ProteinCartilageChondrocytesChondrogenesisCleidocranial DysplasiaCore Binding Factor Alpha 1 SubunitCranial FontanellesDisease ProgressionFracture HealingGene Expression Regulation, DevelopmentalHaploinsufficiencyMiceMice, Mutant StrainsAxin2 protein, mouseAxin ProteinCore Binding Factor Alpha 1 SubunitRunx2 protein, mouseAxin2Cleidocranial dysplasiaEndochondral bone formationRunx2Wnt signaling

Identifiers

PMID24973690
PMCPMC4125446
OpenAlexW2025797813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.